@article{jourdi:hal-02397750,
TITLE = {Potential usefulness of activated charcoal (DOAC remove®) for dRVVT testing in patients receiving Direct Oral AntiCoagulants},
AUTHOR = {Jourdi, G. and Delrue, M. and Stepanian, A. and Valaize, J. and Foulon-Pinto, G. and Demagny, J. and Duchemin, J. and Nedelec-Gac, F. and Darnige, L. and Curis, E. and Delavenne, X. and Gaussem, P. and Siguret, V. and Gouin-Thibault, I.},
URL = {https://univ-rennes.hal.science/hal-02397750},
JOURNAL = {Thrombosis Research},
PUBLISHER = {Elsevier},
VOLUME = {184},
PAGES = {86-91},
YEAR = {2019},
MONTH = Dec, DOI = {10.1016/j.thromres.2019.11.001},
KEYWORDS = {Lupus anticoagulant ; Dabigatran ; Rivaroxaban ; Apixaban ; Antiphospholipid syndrome},
PDF = {https://univ-rennes.hal.science/hal-02397750/file/Jourdi%20et%20al-2019-Potential%20usefulness%20of%20activated%20charcoal%20%28DOAC%20remove%C2%AE%29%20for%20dRVVT%20testing%20in.pdf},
HAL_ID = {hal-02397750},
HAL_VERSION = {v1},
}